Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pegasus Mercantile Inc XTCYF


Primary Symbol: C.LOAN

Cannabis
Pegasus Mercantile Inc., formerly XTACY Therapeutics Corp., is a Canada-based prospect generator that provides companies with financial, operational, and management assistance in the market for wellness consumer products. The Company is focused on global wellness, psychedelics, mycology, hemp and cannabidiol (CBD), healthcare-related target companies and their clinical studies and trials. see more

Recent & Breaking News (CSE:LOAN)

CSE Bulletin: Name and Symbol Change - Xtacy Therapeutics Corp. (XTCY)

Newsfile November 4, 2024

Pegasus Mercantile Corporate Update ( Xtacy Therapeutics Corp.)

TheNewsWire November 1, 2024

XTACY Therapeutics Corporate Update Introduces Itself as Pegasus Mercantile Inc.

TheNewsWire October 28, 2024

XTACY Therapeutics Announces Debt Settlement

Newsfile October 5, 2023

Global Wellness (CSE:GWS) pharma subsidiary supporting cancer therapeutic company AVM Biotechnology

Jonathon Brown December 5, 2022

Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology

Newsfile December 5, 2022

Global Wellness (CSE:GWS) forms pharma subsidiary focused on clinical trials

Jonathon Brown November 17, 2022

Global Wellness Strategies Forms Pharma Subsidiary Focused on Clinical Trials

Newsfile November 17, 2022

Global Wellness Corporate Quarter Highlights

Newsfile June 27, 2022

Global Wellness Readies for First Clinical Trial

Newsfile May 12, 2022

Global Wellness Strategies Closes First Tranche of Non-Brokered Private Placement

Newsfile February 22, 2022

Global Wellness (CSE:GWS) signs MDMA supply agreement

Caroline Egan  February 10, 2022

Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech

Newsfile February 10, 2022

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market

Accesswire January 20, 2022

Global Wellness' Shanti Therapeutics Submits Human Research Ethics Committee (HREC) Application

Newsfile November 29, 2021

Global Wellness' Shanti Therapeutics Files MDMA Methods Patent

Newsfile November 9, 2021

Global Wellness' Meris Kott Speaks at Debut Lift&Co Psychedelics Business Summit

Newsfile November 5, 2021

Global Wellness Strategies Shanti Therapeutics Updates and Symbol Change to GWS

Newsfile October 4, 2021

Global Wellness (CSE:LOAN) signs definitive agreement with Cannvalate Australia

Brieanna McCutcheon  August 9, 2021

Global Wellness Signs Definitive Agreement with Cannvalate Australia

Newsfile August 9, 2021